167 related articles for article (PubMed ID: 27155470)
1. Discovery of a sulfamate-based steroid sulfatase inhibitor with intrinsic selective estrogen receptor modulator properties.
Ouellet C; Maltais R; Ouellet É; Barbeau X; Lagüe P; Poirier D
Eur J Med Chem; 2016 Aug; 119():169-82. PubMed ID: 27155470
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of a tetrahydroisoquinoline derivative as a steroid sulfatase inhibitor and a selective estrogen receptor modulator.
Ouellet C; Ouellet É; Poirier D
Invest New Drugs; 2015 Feb; 33(1):95-103. PubMed ID: 25410727
[TBL] [Abstract][Full Text] [Related]
3. A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.
Rasmussen LM; Zaveri NT; Stenvang J; Peters RH; Lykkesfeldt AE
Breast Cancer Res Treat; 2007 Dec; 106(2):191-203. PubMed ID: 17268816
[TBL] [Abstract][Full Text] [Related]
4. Development of steroid sulfatase inhibitors.
Woo LW; Purohit A; Potter BV
Mol Cell Endocrinol; 2011 Jul; 340(2):175-85. PubMed ID: 21238537
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 3-benzylaminocoumarin-7-O-sulfamate derivatives as steroid sulfatase inhibitors.
Hng Y; Lin MH; Lin TS; Liu IC; Lin IC; Lu YL; Chang CN; Chiu PF; Tsai KC; Chen MJ; Liang PH
Bioorg Chem; 2020 Mar; 96():103618. PubMed ID: 32059152
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of N-acylated tyramine sulfamates containing C-F bonds as steroid sulfatase inhibitors.
Daśko M; Rachon J; Masłyk M; Kubiński K; Demkowicz S
Chem Biol Drug Des; 2017 Jul; 90(1):156-161. PubMed ID: 28032462
[TBL] [Abstract][Full Text] [Related]
7. Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates.
Okada M; Nakagawa T; Iwashita S; Takegawa S; Fujii T; Koizumi N
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):141-8. PubMed ID: 14672734
[TBL] [Abstract][Full Text] [Related]
8. 3Beta-sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors.
Ciobanu LC; Boivin RP; Luu-The V; Poirier D
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):15-26. PubMed ID: 12751816
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of silicon-containing steroid sulfatase inhibitors possessing pro-estrogen antagonistic character.
Kajita D; Nakamura M; Matsumoto Y; Makishima M; Hashimoto Y
Bioorg Med Chem; 2014 Apr; 22(7):2244-52. PubMed ID: 24630694
[TBL] [Abstract][Full Text] [Related]
10. Steroid sulfatase inhibitors: the current landscape.
Anbar HS; Isa Z; Elounais JJ; Jameel MA; Zib JH; Samer AM; Jawad AF; El-Gamal MI
Expert Opin Ther Pat; 2021 Jun; 31(6):453-472. PubMed ID: 33783295
[No Abstract] [Full Text] [Related]
11. Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors.
El-Gamal MI; Semreen MH; Foster PA; Potter BV
Bioorg Med Chem; 2016 Jun; 24(12):2762-7. PubMed ID: 27143133
[TBL] [Abstract][Full Text] [Related]
12. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.
Ishida H; Nakata T; Suzuki M; Shiotsu Y; Tanaka H; Sato N; Terasaki Y; Takebayashi M; Anazawa H; Murakata C; Li PK; Kuwabara T; Akinaga S
Breast Cancer Res Treat; 2007 Dec; 106(2):215-27. PubMed ID: 17268815
[TBL] [Abstract][Full Text] [Related]
13. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agents.
Zaraei SO; Dohle W; Anbar HS; El-Gamal R; Leblond B; Foster PA; Al-Tel TH; Potter BVL; El-Gamal MI
Bioorg Med Chem; 2024 Mar; 101():117645. PubMed ID: 38401456
[TBL] [Abstract][Full Text] [Related]
15. Steroid sulfatase mediated growth Sof human MG-63 pre-osteoblastic cells.
Dias NJ; Selcer KW
Steroids; 2014 Oct; 88():77-82. PubMed ID: 25042472
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of carbon-11-labeled dual aromatase-steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancer.
Wang M; Mickens J; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH
Steroids; 2009 Nov; 74(12):896-905. PubMed ID: 19559719
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.
Daśko M; Przybyłowska M; Rachon J; Masłyk M; Kubiński K; Misiak M; Składanowski A; Demkowicz S
Eur J Med Chem; 2017 Mar; 128():79-87. PubMed ID: 28152429
[TBL] [Abstract][Full Text] [Related]
18. Antisulfatase, Osteogenic, and Anticancer Activities of Steroid Sulfatase Inhibitor EO-33 in Mice.
Poirier D; Roy J; Maltais R; Ayan D
J Med Chem; 2019 Jun; 62(11):5512-5521. PubMed ID: 31062594
[TBL] [Abstract][Full Text] [Related]
19. A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation.
El-Gamal MI; Zaraei SO; Foster PA; Anbar HS; El-Gamal R; El-Awady R; Potter BVL
Bioorg Med Chem; 2020 Apr; 28(8):115406. PubMed ID: 32173116
[TBL] [Abstract][Full Text] [Related]
20. Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Winiski AP; Billich A
J Med Chem; 2003 Nov; 46(23):5091-4. PubMed ID: 14584960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]